Product
GSK3915393
2 clinical trials
3 indications
Indication
Idiopathic Pulmonary FibrosisIndication
Celiac DiseaseIndication
Coeliac DiseaseClinical trial
A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study (TRANSFORM) to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)Status: Not yet recruiting, Estimated PCD: 2026-03-19
Clinical trial
A Randomized, Placebo Controlled, Double Blind, Single and Repeat Dose Escalation Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of GSK3915393 in Healthy Participants and Open Label Assessment of Coadministration of GSK3915393 With Grapefruit Juice and Itraconazole on the Pharmacokinetics of GSK3915393Status: Completed, Estimated PCD: 2021-06-29